Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Viridian Therapeutics

Request full access

Focused on the development therapeutics for the treatment of cardiovascular and muscle diseases

Waltham, United StatesFounded 2007Biotech & Life Sciences

About Viridian Therapeutics

Viridian Therapeutics is a biopharmaceutical company that discovers and develops microRNA (miRNA)-targeting therapies. The company is focused on developing innovative therapies for thyroid eye disease through advanced monoclonal antibody technology targeting the IGF-1R pathway.

Viridian Therapeutics operates in the biopharmaceutical market, specifically focusing on rare autoimmune diseases. Its clients are patients suffering from these conditions. The company's business model revolves around the discovery, development, and subsequent commercialization of novel treatments. As a clinical-stage biopharmaceutical company, its revenue generation will likely depend on the successful approval and market launch of its therapeutic candidates.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2017

Viridian Therapeutics in the Waltham ecosystem

Live from Dealroom

The Viridian Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Boulder Ventures
  • Atlas Venture
  • Broadview Ventures
  • Amgen Ventures
  • Remeditex Ventures

Series B and later8 investors entered at this stage

  • MP Healthcare Venture Management
  • JAFCO
  • Brace Pharma
  • MRL Ventures
  • Fidelity Investments
  • Hercules Capital
  • Braidwell
  • DRI Healthcare
Employees mapped 278 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 18 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$59M

32 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Viridian Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.